Investment in Unconsolidated Entities

3 Months Ended

Mar. 31, 2019

Equity Method Investments and Joint Ventures [Abstract]

We have strategic investments in certain non-publicly traded equity securities that do not have a readily determinable fair value. We measure our equity securities without a readily determinable fair value, other than those accounted for using the equity method, at cost adjusted for changes resulting from impairments, if any, and observable price changes in orderly transactions for the identical or similar securities of the same issuer. For the three months ended March 31, 2019 and 2018, we did not identify any observable price changes requiring an adjustment to our investments.

Our investments in unconsolidated entities consisted of the following:



	As of
	March 31, 2019		December 31, 2018
	(In thousands)
Investments in unconsolidated entities:
Equity method	$	176,043	$	182,035
Other equity investments without a readily determinable fair value	51,785		80,438
Total investments in unconsolidated entities	$	227,828	$	262,473

During the three months ended March 31, 2019, we recorded a $28 million reduction to the carrying amount of one of our investments based on circumstances that indicated the fair value of the investment was less than its carrying amount. There were no similar reductions during the three months ended March 31, 2018.